Skip to content
Home/Companies/Pharma/Frontier Biosolutions

Frontier Biosolutions

Pharma·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Frontier Biosolutions?

Frontier Biosolutions is currently owned by Flerie through Flerie Invest (2011 vintage), since 2023.

Hand-verified · updated 2026-08-17

Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQGermany
SectorPharma
StatusActive

More from Flerie Invest

Other portfolio companies in the same fund.

Mendus
Active
BiotechSweden· 2023
A3P Biomedical
Exited 2025
BiotechSweden· 2022
Alder Therapeutics
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2022
Bohus Biotech
Active
PharmaSweden· 2022
Geneos Therapeutics
Active
BiotechUS· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Frontier Biosolutions

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Frontier Biosolutions?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Frontier Biosolutions.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue